{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/etelcalcetide.json","peptide":{"slug":"etelcalcetide","name":"Etelcalcetide","url":"https://peptidescanner.com/peptides/etelcalcetide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":47,"entries":[{"objectId":"story:clinicaltrials-gov-nct01134549-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01134549","domain":"Clinical trials","dateInSource":"2017-04-14","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01134549-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134549-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01134549-etelcalcetide-v1","contentSha256":"9baa489fa485ddb4d06e3f2c2de1cb025ab528c3eaaa2899d60bbb2dbaee96ff"},{"objectId":"story:clinicaltrials-gov-nct01134562-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01134562","domain":"Clinical trials","dateInSource":"2018-01-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01134562-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01134562-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01134562-etelcalcetide-v1","contentSha256":"315e212fb82e4d86275122785e5a456efa959c8319a0e0acf04b9f2335fa42b5"},{"objectId":"story:clinicaltrials-gov-nct01254565-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01254565","domain":"Clinical trials","dateInSource":"2017-04-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01254565-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01254565-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01254565-etelcalcetide-v1","contentSha256":"0a393b412e08c1fc20de9b1dc6866acea1735f2ecf418c3d9270a5021a586fb1"},{"objectId":"story:clinicaltrials-gov-nct01414114-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01414114","domain":"Clinical trials","dateInSource":"2017-04-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01414114-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01414114-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01414114-etelcalcetide-v1","contentSha256":"4eb1c8e9cfbc0bccbe18a02476c52429a876d3bcf04369c18b2fd8157c7c4340"},{"objectId":"story:clinicaltrials-gov-nct01785849-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01785849","domain":"Clinical trials","dateInSource":"2019-08-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01785849-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785849-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01785849-etelcalcetide-v1","contentSha256":"21c52cb0c4bb555dd72122961ce8dd243806dc0fd397f5cef93711b6554da498"},{"objectId":"story:clinicaltrials-gov-nct01785875-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01785875","domain":"Clinical trials","dateInSource":"2019-04-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01785875-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01785875-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01785875-etelcalcetide-v1","contentSha256":"b5690976748d541e67c680c42abd0ac204ab6cd8376c8313d076ca5d9b21bef3"},{"objectId":"story:clinicaltrials-gov-nct01788046-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01788046","domain":"Clinical trials","dateInSource":"2019-08-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01788046-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01788046-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01788046-etelcalcetide-v1","contentSha256":"89fad0488866182726c82509e6a9d6c8a656101443942a38419cb9a02a504e5c"},{"objectId":"story:clinicaltrials-gov-nct01896232-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01896232","domain":"Clinical trials","dateInSource":"2019-07-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01896232-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01896232-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01896232-etelcalcetide-v1","contentSha256":"7e721c5f5c103029214a62b90e610c3070927a44658a996ab92892b5eb413651"},{"objectId":"story:clinicaltrials-gov-nct01932970-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT01932970","domain":"Clinical trials","dateInSource":"2018-10-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01932970-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct01932970-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct01932970-etelcalcetide-v1","contentSha256":"04e10df796516ad9060fff4563cd8eadf255218746d1758b1fa59e201b54e0d4"},{"objectId":"story:clinicaltrials-gov-nct02102204-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02102204","domain":"Clinical trials","dateInSource":"2017-11-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02102204-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02102204-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct02102204-etelcalcetide-v1","contentSha256":"04983c77988bc4ae039a353cab1d98399d320745a3318e171cc97de79fe3208f"},{"objectId":"story:clinicaltrials-gov-nct02833857-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT02833857","domain":"Clinical trials","dateInSource":"2019-07-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02833857-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct02833857-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct02833857-etelcalcetide-v1","contentSha256":"c06d6f6aa6948f677f1245db313c8d47ecb786b3f5d5c71e0bb42301690c6627"},{"objectId":"story:clinicaltrials-gov-nct03283098-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03283098","domain":"Clinical trials","dateInSource":"2020-02-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03283098-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03283098-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03283098-etelcalcetide-v1","contentSha256":"56b835f78bc82fb7b1a27944905596f3ee392d80103718b46faa72d6c45677d4"},{"objectId":"story:clinicaltrials-gov-nct03299244-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03299244","domain":"Clinical trials","dateInSource":"2021-04-30","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03299244-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03299244-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03299244-etelcalcetide-v1","contentSha256":"81c3bc8af3f42e8eaf6aaa8cc241b0e689ebf906f1bea3cbdd53bab5ca2265b5"},{"objectId":"story:clinicaltrials-gov-nct03633708-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03633708","domain":"Clinical trials","dateInSource":"2026-02-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03633708-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03633708-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03633708-etelcalcetide-v1","contentSha256":"0ce8983a52e04004247ec54e7e1f994a8ef40f77051a5ef50a2c23a15673ac6f"},{"objectId":"story:clinicaltrials-gov-nct03795558-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03795558","domain":"Clinical trials","dateInSource":"2022-03-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03795558-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03795558-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03795558-etelcalcetide-v1","contentSha256":"c8ae750aec358efa6fa0d1a1df3e391db87bc152ba732f7dfb7b65a8eb9d6fc7"},{"objectId":"story:clinicaltrials-gov-nct03960437-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03960437","domain":"Clinical trials","dateInSource":"2023-09-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03960437-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03960437-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03960437-etelcalcetide-v1","contentSha256":"bb80f1d628dbed1960599e2aa8f8cb9b6fc044f628d2959760830da9fa45eb29"},{"objectId":"story:clinicaltrials-gov-nct03969329-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT03969329","domain":"Clinical trials","dateInSource":"2026-08-21","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03969329-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#clinicaltrials-gov-nct03969329-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#clinicaltrials-gov-nct03969329-etelcalcetide-v1","contentSha256":"a6594d8f3d4a1178728af858cc981dc1f4c0eeeb19904643c5b2309e73fc1974"},{"objectId":"story:fda-drugs-nda208325:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA208325","domain":"Regulatory","dateInSource":"2017-02-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda208325/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#fda-drugs-nda208325-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#fda-drugs-nda208325-v1","contentSha256":"3e975597818d1cda2fdddcfa6762d3e39c2e782724bc7859485c3ae2f97f107c"},{"objectId":"story:federal-register-2018-28221:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2018-28221","domain":"Regulatory","dateInSource":"2018-12-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2018-28221/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#federal-register-2018-28221-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#federal-register-2018-28221-v1","contentSha256":"10265bbdbb0c3e0e5d25593152dd3e1a81291772b4280abc4dfc84b553eacb23"},{"objectId":"story:pubmed-pmid-27639083-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-27639083-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-27639083-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-27639083-etelcalcetide-v1","contentSha256":"9d6da84f6280f053ae1d8d866f6e15c32d25aacb1c8df5fe43b617fb3bd68c5a"},{"objectId":"story:pubmed-pmid-28063122-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.","domain":"Literature metadata","dateInSource":"2026-10-11","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28063122-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28063122-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28063122-etelcalcetide-v1","contentSha256":"277dd4469064d0b3db69cf6f56d71be921d5a923a7a2edfb5e4c8bec734e7867"},{"objectId":"story:pubmed-pmid-28277829-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide for the treatment of secondary hyperparathyroidism.","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28277829-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28277829-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28277829-etelcalcetide-v1","contentSha256":"6f0fae6242c40f7024585b0c157aa4afef2c74b4fbc7767d4bf6f9bd5165500c"},{"objectId":"story:pubmed-pmid-28508378-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Population Pharmacokinetic and Pharmacodynamic Modeling of Etelcalcetide in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis.","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28508378-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28508378-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28508378-etelcalcetide-v1","contentSha256":"8a897acb6977c867da954f7ef6798ff99f6c4b90f62ca81ae8f7fef8b1093e91"},{"objectId":"story:pubmed-pmid-28615947-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide.","domain":"Literature metadata","dateInSource":"2024-03-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28615947-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28615947-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28615947-etelcalcetide-v1","contentSha256":"a0ee2f6abc7fd820260030fa83d7cf47c9658ccdd7beac4f77ba6602648aee98"},{"objectId":"story:pubmed-pmid-28661841-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Parsabiv Could Be Pricey Addition In Care for CKD, ESRD Patients.","domain":"Literature metadata","dateInSource":"2019-05-23","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28661841-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28661841-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28661841-etelcalcetide-v1","contentSha256":"e9ddf090149d2617c753669a3b4531e2c410228ae7200555addfca919c328ff3"},{"objectId":"story:pubmed-pmid-28867373-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathy…","domain":"Literature metadata","dateInSource":"2021-12-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-28867373-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-28867373-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-28867373-etelcalcetide-v1","contentSha256":"b23384b9cd286b029a48fb4cb6feb83ef6997ba4b64eb465cb6356c34645210d"},{"objectId":"story:pubmed-pmid-29276237-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Formulary Drug Review: Etelcalcetide.","domain":"Literature metadata","dateInSource":"2019-11-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29276237-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29276237-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29276237-etelcalcetide-v1","contentSha256":"2e280f3ed70aa93ee9e5d5bc4694f5133fc3bab8539fcb43c514f692272efc42"},{"objectId":"story:pubmed-pmid-29440923-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.","domain":"Literature metadata","dateInSource":"2024-03-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29440923-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29440923-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29440923-etelcalcetide-v1","contentSha256":"dc8c27cf8107a5df07882546d2fceb120d801680f3b1920189ed228655668bc8"},{"objectId":"story:pubmed-pmid-29691773-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.","domain":"Literature metadata","dateInSource":"2026-10-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29691773-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29691773-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29691773-etelcalcetide-v1","contentSha256":"a0b6f5062468c793c54c1584d1eabdbd1783b44e617daae36739aab73197432c"},{"objectId":"story:pubmed-pmid-29719376-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.","domain":"Literature metadata","dateInSource":"2024-11-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29719376-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29719376-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29719376-etelcalcetide-v1","contentSha256":"b9852f0e157a9c15e73b8f6adbfc1421bdbc945fc9835768d6f56f5b4dcc3108"},{"objectId":"story:pubmed-pmid-29786181-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"[New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy].","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29786181-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29786181-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29786181-etelcalcetide-v1","contentSha256":"763b9b777211098dde9a4e53c6644939f4c9b012eec7bc048dbc762f9857b469"},{"objectId":"story:pubmed-pmid-29927050-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide.","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-29927050-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-29927050-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-29927050-etelcalcetide-v1","contentSha256":"56a680b87d94d5b06ee08df825a933d2a3892eaa40d806ffe56d10367c876dd3"},{"objectId":"story:pubmed-pmid-30009474-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Treatment of secondary hyperparathyroidism: How do cinacalcet and etelcalcetide differ?","domain":"Literature metadata","dateInSource":"2019-12-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30009474-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30009474-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-30009474-etelcalcetide-v1","contentSha256":"fc413ff7c839b65de95df24a56808949b6f5091e4bf2797ad6f874f0af641b0e"},{"objectId":"story:pubmed-pmid-30013296-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide (Parsabiv) for Secondary Hyperparathyroidism in Adults With Chronic Kidney Disease on Hemodialysis.","domain":"Literature metadata","dateInSource":"2024-11-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-30013296-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-30013296-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-30013296-etelcalcetide-v1","contentSha256":"1078236e7df1bb876353ce4e46b1f59ca05cec54e0a15867394051cc83f19c0e"},{"objectId":"story:pubmed-pmid-31853791-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology.","domain":"Literature metadata","dateInSource":"2021-06-04","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-31853791-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-31853791-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-31853791-etelcalcetide-v1","contentSha256":"551e2087da2fb0218bf12812271b8196afe2a000e8b385484dfb3e25ca916ea5"},{"objectId":"story:pubmed-pmid-33305109-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"A Prospective, Randomized Clinical Trial of Etelcalcetide in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism (the DUET Trial).","domain":"Literature metadata","dateInSource":"2023-11-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33305109-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33305109-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-33305109-etelcalcetide-v1","contentSha256":"e8266266918f64fbe21b8f5df2f90dbb203ffb5fe721f680d6fbc9dc5abb1ff6"},{"objectId":"story:pubmed-pmid-33825489-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis.","domain":"Literature metadata","dateInSource":"2022-01-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-33825489-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-33825489-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-33825489-etelcalcetide-v1","contentSha256":"9fafd066bf587ec6c82b814325fe8a502211ed4c14070260ee55b83e6e455f9c"},{"objectId":"story:pubmed-pmid-34787825-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride.","domain":"Literature metadata","dateInSource":"2022-07-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-34787825-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-34787825-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-34787825-etelcalcetide-v1","contentSha256":"79fe80fee0ac7ca3d8b3cf3321cc9c72fc862dcf58ebd988b7618d70540b3af4"},{"objectId":"story:pubmed-pmid-36611532-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation.","domain":"Literature metadata","dateInSource":"2023-03-08","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36611532-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36611532-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-36611532-etelcalcetide-v1","contentSha256":"90044286c72a01ebf5036bd688fb727995fb8f42e258056c37566fe87c3d15a9"},{"objectId":"story:pubmed-pmid-36790677-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study.","domain":"Literature metadata","dateInSource":"2026-10-31","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-36790677-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-36790677-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-36790677-etelcalcetide-v1","contentSha256":"c531a6dfe27ed3839e2843f1225381317bc974bbe7f527367e4b5587fbb42e9c"},{"objectId":"story:pubmed-pmid-37383843-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide.","domain":"Literature metadata","dateInSource":"2024-03-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-37383843-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-37383843-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-37383843-etelcalcetide-v1","contentSha256":"70e40a64d0e852cabd341fb6cc1211a3afc4115ed4aec41463d5624c0684f54a"},{"objectId":"story:pubmed-pmid-38050530-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.","domain":"Literature metadata","dateInSource":"2023-12-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-38050530-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-38050530-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-38050530-etelcalcetide-v1","contentSha256":"e41cb01011f42163833e0d57c4d7e6fb637b740630ebcae48db0155c46b4539a"},{"objectId":"story:pubmed-pmid-39081745-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation.","domain":"Literature metadata","dateInSource":"2026-05-18","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39081745-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39081745-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-39081745-etelcalcetide-v1","contentSha256":"e8baa2406def14b6c752057df7f82f4d50c886877f21f2833cd6b0d03ddf4b6e"},{"objectId":"story:pubmed-pmid-39557587-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Real world evaluation of etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients in Argentina.","domain":"Literature metadata","dateInSource":"2026-09-10","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39557587-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-39557587-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-39557587-etelcalcetide-v1","contentSha256":"4afcd2e005cdc99288ad06c7c862c2b8d9c591d5aa8d66628096917a373f0818"},{"objectId":"story:pubmed-pmid-41307414-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Measurement of ionized calcium with a point-of-care ionometer during etelcalcetide therapy.","domain":"Literature metadata","dateInSource":"2026-09-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41307414-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-41307414-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-41307414-etelcalcetide-v1","contentSha256":"7e4594d5c9c8edaf4840427d875371214f96657dcf9bb277cfdd33a1e9265d78"},{"objectId":"story:pubmed-pmid-42739661-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Etelcalcetide Versus Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis Patients: A Multicentre Comparison with 24 Months of Follow-Up.","domain":"Literature metadata","dateInSource":"2026-09-16","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42739661-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42739661-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-42739661-etelcalcetide-v1","contentSha256":"19dc56f5c6615dc52dfa64f98e4c43cd560268eb0bffa319220fe82945759d46"},{"objectId":"story:pubmed-pmid-42853437-etelcalcetide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia.","domain":"Literature metadata","dateInSource":"2026-10-12","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42853437-etelcalcetide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.json#pubmed-pmid-42853437-etelcalcetide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/etelcalcetide.md#pubmed-pmid-42853437-etelcalcetide-v1","contentSha256":"dab83f00551b80fc9963978826668acd31c6986df313195c242fcdb4d3b5a4ed"}]}
